News & Media

HomeNewsPage 3

20 November 2020

Every second salmon in Europe originates from Benchmark Genetics

Many people working in the aquaculture industry, will have realised that Benchmark Genetics is a significant supplier of ova to Norwegian hatcheries. Still, the fact that the company also has extensive market shares in Europe is perhaps less well known.

9 November 2020

Benchmark Genetics signs seven-year agreement with Norwegian land-based salmon project Salmon Evolution

Salmon Evolution and Benchmark Genetics Norway have entered into an agreement on collaboration on genetics, ova, product deliveries and expertise development related to related to land-based salmon farming.

3 November 2020

Benchmark Genetics has signed a 5-year ova agreement with AquaCon

The contract between Benchmark Genetics and AquaCon involves deliveries of genetics to the land-based facilities that AquaCon are planning to build in Maryland, USA. Benchmark’s Icelandic company, StofnFiskur, will supply approximately 40 million ova to AquaCon over five years. The agreement confirms and consolidates Benchmark’s strong position as a genetics supplier to land-based farming worldwide. Benchmark Genetics has been producing […]

23 October 2020

Interview with Borghild Hillestad, Genetics Manager at Benchmark Genetics Norway

In the first of a series of Benchmark interviews with women leading the way in aquaculture, Genetics Manager Borghild Hillestad tells us how a fluke chance led her to a career in Animal Science, what advice she would give to young people starting out in the industry and why sting rays are her favourite aquatic animals.   How long have […]

12 October 2020

Benchmark Genetics Chile becomes a member of industry association, SalmonChile

Benchmark Genetics Chile (BGCL) are delighted to announce the company has been accepted as a member of industry association, SalmonChile. With over 50 members, SalmonChile’s main objective is to work together both nationally and internationally to address the health, environment, regulatory, social, and financial challenges facing the salmon sector, placing sustainability at its driving force. “We are proud to be […]

28 September 2020

Benchmark’s Spring Genetics signs agreement with Africa’s largest integrated tilapia producer, Lake Harvest

Spring Genetics,  Benchmark’s tilapia genetics business, , today announced it has signed a five year broodstock agreement with Africa’s leading tilapia producer, Lake Harvest Group.

25 September 2020

Benchmark funded research by the Institute of Aquaculture, University of Stirling shortlisted for 2020 Global Aquaculture Alliance Awards

Benchmark Animal Health have contributed to the pioneering work of Researcher Simao Zacarias from the Institute of Aquaculture on non-ablated broodstock shrimp

17 September 2020

Benchmark Genetics (StofnFiskur) awarded ‘Aquaculture Supplier of the Year’ at the 2020 Aquaculture Awards

Benchmark Genetics’ StofnFiskur is the winner for the Aquaculture Awards 2020 in the category “Aquaculture supplier of the year”! Congratulations to the StofnFiskur and everyone in the Benchmark Genetics team! The winners were announced at an entertaining awards ceremony yesterday, which is now available to watch online. “Standing out from the crowd is no mean feat in such an innovative and […]

15 September 2020

New milestone — 100 million eggs delivered from SalmoBreed Salten

Today SalmoBreed Salten AS, which is owned by Benchmark Genetics, has reached a new milestone with the delivery of 100 million eggs since its inception.

13 September 2020

Benchmark shortlisted for three awards in the Aquaculture Awards 2020

An impressive range of companies, research organisations and individuals from around the world have made the shortlists for the 2020 Aquaculture Awards. These awards highlight the range of talent and cutting-edge advances in the technology involved in the global aquaculture sector. We are delighted to be among the companies nominated in different categories.

23 July 2020

Sale of vaccine manufacturing assets to Cell and Gene Therapy Catapult

Benchmark is pleased to announce that it has entered into a Business Purchase Agreement relating to the business and assets comprising its vaccine manufacturing facility at Braintree, UK to Cell and Gene Therapy Catapult  for £16m payable in cash on completion.

20 July 2020

New Artemia innovation drives efficiency in shrimp and fish hatcheries

New tools launched by INVE Aquaculture – part of Benchmark – provides farmers with the best tools to drive efficiency in hatcheries. The SEP-Art Tools are a sustainable solution designed to maintain quality nauplii, reduce losses and ensure safety for workers and the environment.

1 July 2020

Benchmark Animal Health launches in Chile

The establishment of BAHC follows the launch of Benchmark Genetics in Chile in 2018 and represents a strategic move into the world’s second largest salmon market.

1 July 2020

Fish Vet Group acquired by Zoetis

Benchmark announces that it has completed the sale of its wholly owned subsidiary FVG Ltd. ("FishVet") to Pharmaq, part of the global animal health company Zoetis.